Skip to main content
. 2021 Jun 26;10(13):e019864. doi: 10.1161/JAHA.120.019864

Table 2.

Functional Status Measures at Baseline Stratified by Concordant and Discordant Group Assignment

Characteristic Favorable VE/VCO2 Slope Unfavorable VE/VCO2 Slope P Value*

High

KCCQ‐CS, Concordant–Lower Severity, N=566, 27.4%

Low

KCCQ‐CS, Discordant: Symptom Magnifier,

N=480, 23.3%

High

KCCQ‐CS, Discordant: Symptom Minimizer,

N=465, 22.6%

Low

KCCQ‐CS,

Concordant–Higher Severity,

N=551, 26.7%

Distance of 6 min walk, m, N=2016 411 (350–463) 367 (297–442) 377 (318–430) 323 (251–394) <0.001
Cardiopulmonary exercise duration, min, N=2044 12 (9–14) 10 (7–12), § 9 (7–11) 8 (6–10) <0.001
Borg rating at peak exercise, N=1998 17 (15–18) 17 (15–19) § , 17 (15–19) 17 (15–19) <0.001
VE/VCO2 28 (26–31) 28 (26–31) 38 (35–43) 39 (35–46) N/A
Peak VO2, mL/kg per min, N=2061 17 (14–20) 15 (13–19), # 13 (11–16) 12 (10–15) <0.001
Oxygen uptake efficiency slope, N=2053 2.0 (1.6–2.4) 2.0 (1.6–2.4)# 1.3 (1.0–1.6) 1.3 (1.0–1.7) <0.001
VO2 at the ventilatory threshold, mL/kg per min, N=1771 12 (10–14) 11 (9–13), # 10 (9–12) 10 (8–11) <0.001

Values are presented as median (interquartile range) for continuous variables and number (percent) for categorical variables. Because of missing data, N is listed for those variables where the cohort with available data was less than N=2062. KCCQ‐CS indicates Kansas City Cardiomyopathy Questionnaire Clinical Summary score; VE/VCO2, minute ventilation/carbon dioxide production; and VO2, oxygen uptake.

*

P for comparison among all 4 groups.

P<0.001 vs concordant–lower severity group.

P<0.001 vs concordant–higher severity group.

§

P<0.05 vs symptom minimizer group.

P<0.05 vs concordant–lower severity group.

P<0.05 vs concordant–higher severity group.

#

P<0.001 vs symptom minimizer group.